Your browser doesn't support javascript.
loading
The implementation status of prehabilitation during neoadjuvant chemotherapy for patients with locally advanced esophageal cancer: a questionnaire survey to the board-certified facilities in Japan.
Harada, Tsuyoshi; Tsuji, Tetsuya; Fukushima, Takuya; Ikeda, Tomohiro; Toyama, Shusuke; Konishi, Nobuko; Nakajima, Hiroki; Suzuki, Katsuyoshi; Matsumori, Keiji; Yanagisawa, Takumi; Hashimoto, Kakeru; Kagaya, Hitoshi; Zenda, Sadamoto; Kojima, Takashi; Fujita, Takeo; Ueno, Junya; Hijikata, Nanako; Ishikawa, Aiko; Hayashi, Ryuichi.
Afiliación
  • Harada T; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. tsuyoshi6167@gmail.com.
  • Tsuji T; Department of Rehabilitation Medicine, Keio University Graduate School, Shinjuku, Tokyo, Japan. tsuyoshi6167@gmail.com.
  • Fukushima T; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Ikeda T; Department of Rehabilitation Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
  • Toyama S; Faculty of Rehabilitation, Kansai Medical University, Hirakata, Osaka, Japan.
  • Konishi N; Department of Rehabilitation Medicine, Okayama University Hospital, Okayama, Okayama, Japan.
  • Nakajima H; Department of Physical Therapy Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan.
  • Suzuki K; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Matsumori K; Department of Rehabilitation, Nagoya University Hospital, Nagoya, Aichi, Japan.
  • Yanagisawa T; Division of Rehabilitation Medicine, Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan.
  • Hashimoto K; Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Nagano, Japan.
  • Kagaya H; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Zenda S; Department of Rehabilitation, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Kojima T; Department of Rehabilitation, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Fujita T; Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Ueno J; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Hijikata N; Department of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Ishikawa A; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Hayashi R; Department of Rehabilitation Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Esophagus ; 21(4): 496-504, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39048749
ABSTRACT

BACKGROUND:

Prehabilitation during neoadjuvant therapy has the potential to improve clinical outcomes. However, information on its global dissemination status is limited. This Japanese nationwide survey investigated the implementation status of and barriers to prehabilitation during neoadjuvant chemotherapy (NAC) for patients with locally advanced esophageal cancer in hospitals.

METHODS:

This multicenter nationwide survey was conducted by post. The eligible facilities were 155 Japanese hospitals that had been certified within the last 10 years as authorized institutes for board-certified esophageal surgeons by the Japan Esophageal Society. We administered an original questionnaire to investigate the current status of prehabilitation during NAC.

RESULTS:

The response rate was 75% (117/155 facilities). Forty-six facilities (39%) provided prehabilitation during NAC. The most frequently selected reasons for not providing or providing insufficient prehabilitation were lack of human resources, issues with the reimbursement of medical fees, difficulty in providing continuous prehabilitation during repeated inpatient and outpatient care, the lack of established standard prehabilitation programs, challenges in providing multidisciplinary prehabilitation, and difficulty in managing physical symptoms.

CONCLUSION:

We observed that the implementation rate of prehabilitation during NAC was low. Critical reasons were not only the lack of medical resources but also the lack of evidence-based standard prehabilitation programs during NAC and the lack of evidence for how to continuously deliver prehabilitation during NAC to patients with physical symptoms.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Terapia Neoadyuvante Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Esophagus Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Terapia Neoadyuvante Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Esophagus Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón